Conservative surgical management of small-volume stage IB1 cervical cancer

Authors: Naik; Cross1; Nayar1; Mayadevi2; Lopes2; Godfrey2; Hatem2

Source: BJOG: An International Journal of Obstetrics & Gynaecology, Volume 114, Number 8, August 2007 , pp. 958-963(6)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Objective

To determine outcomes of women with small-volume stage IB1 disease managed by conservative surgical treatment. Design

A retrospective review. Setting

The Northern Gynaecological Oncology Center, Queen Elizabeth Hospital, Gateshead, UK. Population

Women with stage IB1 cervical cancer who were managed by conservative surgery over a 6-year period between 1 January 2000 and 31 December 2005. Main outcome measures

Pelvic lymph node metastases, recurrence rates and outcome survival. Results

A total of 17 women with conservatively managed stage IB1 cervical cancer were identified. Their ages were 25-67 years, median 37 years, 4 women were nulliparous. All women presented with an abnormal screening smear showing at least severe dyskaryosis. Estimated tumour volumes ranged from 16 to 640 mm3, median 72 mm3. Four women showed multifocal invasion. All four nulliparous women and one parous woman underwent fertility-sparing treatment, i.e. loop cone ± laparoscopic pelvic node dissection. The other 12 women underwent laparoscopic assisted vaginal hysterectomy/total abdominal hysterectomy ± pelvic lymph node dissection. There were no cases of residual disease in any of the definitive treatment specimens. There were no cases of metastatic spread to pelvic lymph nodes. To date, no women have developed recurrent disease, and all women are alive and well (median follow up, 29 months). Conclusions

The conservative surgical management of small-volume stage IB1 cases in this series showed an excellent outcome with no cases showing pelvic lymph node involvement and no cases developing recurrent disease. A more formal assessment of tumour volume with a more active approach to determining the third dimension will allow more women the option of conservative treatment, thereby minimising the adverse effects of radical surgery.

Keywords: Cancer; cervix; stage; surgery; treatment

Document Type: Research article

DOI: 10.1111/j.1471-0528.2007.01408.x

Affiliations: 1: Department of Pathology, Queen Elizabeth Hospital, Sheriff Hill, Gateshead, UK 2: Northern Gynaecological Oncology Centre

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A